financetom
Business
financetom
/
Business
/
Govt to launch second attempt to sell Air India next week with a Mumbai roadshow
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Govt to launch second attempt to sell Air India next week with a Mumbai roadshow
Oct 18, 2019 12:54 PM

After a failed attempt last year, the government is all set to launch a second bid to sell the debt-ridden national carrier Air India. Sources in the government say roadshows could begin as early as next week and an expression of interest is likely in a couple of weeks. Government plans to kick-start the roadshows from Mumbai and is also planning overseas roadshows including one in London to gauge the feedback from investors.

In July, the government reconstituted the panel tasked with the divestment of Air India. A group of ministers called the Air India Specific Alternative Mechanism, headed by home minister Amit Shah, comprising three other ministers was set up. The earlier panel had five members. The other ministers in the panel are finance minister Nirmala Sitharaman, commerce, and railway minister Piyush Goyal and civil aviation minister Hardeep Singh Puri. The union cabinet gave its green signal to initiate the sale process last week.

A special purpose vehicle of Air India, AIAHL has mopped up a total of Rs 21,985 crore by way of bond issues since September 16 and the proceeds would be utilised to repay the debt of the national carrier.

The civil aviation ministry on Wednesday said the third bond issue of AIAHL was fully subscribed. The issue of 10-year tenure bonds worth Rs 1,000 crore with a greenshoe option of Rs 7,064 crore received bids to the tune of Rs 15,100 crore.

These bonds have been subscribed at a rate of 7.39 percent.

"The company received bids worth Rs 15,100 cr. The company has decided to accept the issue of Rs 7,985 crore," the ministry said in a tweet.

AIAHL had raised Rs 7,000 crore each on September 16 and October 10, respectively.

The government is preparing to divest its stake in loss-making Air India and the final contours are expected to be finalised in the coming days. The airline has a debt burden of more than Rs 54,000 crore.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
PharmaCorp Rx up 10% as Announces Pharmacy Acquisition
PharmaCorp Rx up 10% as Announces Pharmacy Acquisition
May 25, 2026
11:14 AM EDT, 05/25/2026 (MT Newswires) -- PharmaCorp Rx (PCRX.V), up 10.4% on last look, is acquiring a PharmaChoice Canada-bannered pharmacy in Morrisburg, Ontario, for $8.2 million, the company said on Monday. PharmaCorp had executed letters of intent earlier this year regarding four additional pharmacy acquisitions. The Morrisburg pharmacy is the first conversion of the LOIs into a share purchase...
WonderFi Technologies Announces CIRO Approval for Acquisition by Robinhood; WonderFi Shares up 5.9%
WonderFi Technologies Announces CIRO Approval for Acquisition by Robinhood; WonderFi Shares up 5.9%
May 25, 2026
10:31 AM EDT, 05/25/2026 (MT Newswires) -- WonderFi Technologies' ( WONDF ) wholly-owned subsidiary, Coinsquare Capital Markets Ltd (CCML), received regulatory approval from the Canadian Investment Regulatory Organization (CIRO) for Robinhood Markets, Inc's previously announced acquisition of WonderFi ( WONDF ) pursuant to a statutory plan of arrangement under the Business Corporations Act (British Columbia), the company said on Monday....
ImmunityBio (IBRX) Facing Lawsuit After FDA Flags Misleading Cancer Claims, Shares Plunge 21%, $2B Market Cap Lost -- HBSS
ImmunityBio (IBRX) Facing Lawsuit After FDA Flags Misleading Cancer Claims, Shares Plunge 21%, $2B Market Cap Lost -- HBSS
May 25, 2026
SAN FRANCISCO, May 25, 2026 (GLOBE NEWSWIRE) -- ImmunityBio, Inc. ( IBRX ) faces a securities class action lawsuit which seeks to represent investors who purchased or otherwise acquired ImmunityBio ( IBRX ) securities between January 19, 2026 and March 24, 2026. The lawsuit follows news that the FDA sent a warning letter to the company concerning claims made by...
Atlas Engineered Products Q1 Loss Widens
Atlas Engineered Products Q1 Loss Widens
May 25, 2026
10:39 AM EDT, 05/25/2026 (MT Newswires) -- Atlas Engineered Products ( APEUF ) , down 3% on last look, said on Monday that first-quarter net loss widened as revenue fell. Net loss for the quarter ended March 31, widened to $1.73 million, or $0.02 per diluted share, from a loss of $0.85 million, or $0.01 per diluted share, in the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved